Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment

Author(s): Xueyuan Gu, Jianxun Ding, Zhiyu Zhang, Qin Li, Xiuli Zhuang, Xuesi Chen

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 36 , 2015

Become EABM
Become Reviewer


Osteosarcoma (OS) is one of the most serious malignancies along with a high incidence in children and teenagers. Although the neoadjuvant chemotherapy of OS has made great progress and prolongs the five-year survival rates of patients to some extent, drugs are restrained from clinical application due to the unsatisfactory efficacy and severe side effects, especially for the systemic therapy through intravenous injection. The polymeric nanoparticles as anti-cancer drug nanocarriers make OS treatment more promising and effective. Specifically, various polymeric nanoparticles have been developed to overcome the difficulties in targeting delivery of drugs to OS tissue and/or cells through passive and/or active strategies. This review presents an overview on the development of polymeric nanoparticles for anti-cancer drug delivery in OS treatment, and briefly describes the challenge and opportunity for future development.

Keywords: Active targeting, controlled drug delivery, osteosarcoma therapy, passive targeting, polymeric nanocarriers.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [5187 - 5197]
Pages: 11
DOI: 10.2174/1381612821666150923095618
Price: $65

Article Metrics

PDF: 36
PRC: 1